Eligibility: Albertans 5 and older with eligible immunocompromising conditions.Three-dose primary series for immunocompromised 5+ Individuals taking certain medications for autoimmune diseases including rituximab, ocrelizumab, ofatumumab and methotrexate.Recipients of active cancer treatment (chemotherapy, immunotherapy or targeted therapies), excluding those receiving only hormonal therapy, radiation therapy or surgery.Individuals with chronic kidney disease receiving regular dialysis.Transplant recipients, including solid organ and hematopoietic stem cell transplants.Recipients of immunosuppressive therapies (for example, anti-B cell therapies, high-dose systemic corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents).Individuals with advanced untreated HIV infection or acquired immunodeficiency syndrome (AIDS).Individuals with moderate to severe primary immunodeficiency (for example, DiGeorge syndrome, Wiskott-Aldrich syndrome).Recipients of chimeric antigen receptor (CAR)-T-cell therapy.Individuals with certain immunocompromising conditions should receive a 3-dose primary series, followed by all of the booster doses they are eligible for. This is to provide stronger protection because their immune systems respond differently to vaccines than other people without these conditions.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |